The European Commission has warned consumers about an obesity drug currently sold on the Internet which has not passed the safety evaluation process of the European Medicines Agency (EMEA). A recent survey identified 170 medicines found in counterfeit distribution channels, mainly on the Internet, in 2000-2005. The most popular illicit products identified include lifestyle drugs, growth hormones for body-building use and sleeping pills. Illegal copies of licensed medicines such Viagra (sildenafil) or Tamiflu (oseltamivir) have also been sold.
The Commission is particularly concerned about French drugmaker Sanofi-Aventis' Acomplia (rimonabant), which is currently under evaluation by the EMEA.
Commissioner Gunter Verheugen, responsible for enter-prise and industry, said he is "alarmed at the ever increas-ing number of counterfeit medicines sold via the Internet. This represents a real danger to the health of patients."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze